Cutler Group LP Deciphera Pharmaceuticals, Inc. Transaction History
Cutler Group LP
- $307 Million
- Q1 2024
A detailed history of Cutler Group LP transactions in Deciphera Pharmaceuticals, Inc. stock. As of the latest transaction made, Cutler Group LP holds 300 shares of DCPH stock, worth $0. This represents 0.0% of its overall portfolio holdings.
Number of Shares
300
Previous 500
40.0%
Holding current value
$0
Previous $8,000
50.0%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding DCPH
# of Institutions
7Shares Held
343KCall Options Held
500Put Options Held
0-
Jefferies Group LLC New York, NY175KShares$00.03% of portfolio
-
Virginia Retirement Systems Et Al Richmond, VA81KShares$00.01% of portfolio
-
Deka Bank Deutsche Girozentrale50KShares$00.0% of portfolio
-
Credit Suisse Ag Zurich, V836KShares$00.0% of portfolio
-
Wipfli Financial Advisors Llc,204Shares$00.0% of portfolio
About Deciphera Pharmaceuticals, Inc.
- Ticker DCPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 66,822,100
- Description
- Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...